JP2002534508A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534508A5
JP2002534508A5 JP2000593588A JP2000593588A JP2002534508A5 JP 2002534508 A5 JP2002534508 A5 JP 2002534508A5 JP 2000593588 A JP2000593588 A JP 2000593588A JP 2000593588 A JP2000593588 A JP 2000593588A JP 2002534508 A5 JP2002534508 A5 JP 2002534508A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
alkoxy
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000593588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002534508A (ja
JP4653314B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/000172 external-priority patent/WO2000042020A1/en
Publication of JP2002534508A publication Critical patent/JP2002534508A/ja
Publication of JP2002534508A5 publication Critical patent/JP2002534508A5/ja
Application granted granted Critical
Publication of JP4653314B2 publication Critical patent/JP4653314B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000593588A 1999-01-15 2000-01-12 Pde−iv阻害作用を有するフェニルフェナントリジン Expired - Fee Related JP4653314B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100694 1999-01-15
EP99100694.1 1999-01-15
PCT/EP2000/000172 WO2000042020A1 (en) 1999-01-15 2000-01-12 Phenylphenanthridines with pde-iv inhibiting activity

Publications (3)

Publication Number Publication Date
JP2002534508A JP2002534508A (ja) 2002-10-15
JP2002534508A5 true JP2002534508A5 (https=) 2007-03-01
JP4653314B2 JP4653314B2 (ja) 2011-03-16

Family

ID=8237351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593588A Expired - Fee Related JP4653314B2 (ja) 1999-01-15 2000-01-12 Pde−iv阻害作用を有するフェニルフェナントリジン

Country Status (32)

Country Link
US (1) US6476025B1 (https=)
EP (2) EP1650193A3 (https=)
JP (1) JP4653314B2 (https=)
KR (1) KR100720906B1 (https=)
CN (1) CN1152864C (https=)
AT (1) ATE312081T1 (https=)
AU (1) AU774868B2 (https=)
BG (1) BG65126B1 (https=)
BR (1) BR0007527B1 (https=)
CA (1) CA2359440C (https=)
CY (1) CY1106436T1 (https=)
CZ (1) CZ300366B6 (https=)
DE (1) DE60024581T2 (https=)
DK (1) DK1147089T3 (https=)
EA (1) EA003780B1 (https=)
EE (1) EE05105B1 (https=)
ES (1) ES2254132T3 (https=)
HK (1) HK1040997B (https=)
HR (1) HRP20010578A2 (https=)
HU (1) HU227624B1 (https=)
ID (1) ID29070A (https=)
IL (2) IL144026A0 (https=)
NO (1) NO320182B1 (https=)
NZ (1) NZ512872A (https=)
PL (1) PL205670B1 (https=)
RS (1) RS50297B (https=)
SI (1) SI1147089T1 (https=)
SK (1) SK286946B6 (https=)
TR (2) TR200501553T2 (https=)
UA (1) UA69436C2 (https=)
WO (1) WO2000042020A1 (https=)
ZA (1) ZA200104864B (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006238A1 (en) * 2000-07-14 2002-01-24 Altana Pharma Ag Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
AU2003253408A1 (en) * 2002-08-17 2004-03-11 Nycomed Gmbh Novel phenanthridines
CA2495827C (en) 2002-08-29 2012-05-08 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2281658T3 (es) * 2002-08-29 2007-10-01 Nycomed Gmbh 3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
US6894061B2 (en) 2002-12-04 2005-05-17 Wyeth Substituted dihydrophenanthridinesulfonamides
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
CA2533636A1 (en) * 2003-07-31 2005-02-10 Altana Pharma Ag Novel 6-phenylphenanthridines
WO2005023253A1 (en) * 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
AU2005212857B2 (en) * 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
CN104803974A (zh) 2004-03-03 2015-07-29 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
JP2007527899A (ja) * 2004-03-09 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト 新規のイソアミド置換されたヒドロキシ−6−フェニルフェナントリジン
CA2558390A1 (en) * 2004-03-10 2005-09-22 Altana Pharma Ag Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
JP2007527901A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト アミド置換された新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
EP1725532A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
CA2579000C (en) * 2004-09-08 2013-02-05 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
US7411093B2 (en) * 2004-12-20 2008-08-12 Hoffman-La Roche Inc. Aminocycloalkanes as DPP-IV inhibitors
ES2337083T3 (es) * 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
AU2006222060B2 (en) 2005-03-08 2011-09-01 Takeda Gmbh Roflumilast for the treatment of diabetes mellitus
CA2599368A1 (en) * 2005-03-09 2006-09-14 Nycomed Gmbh Amido-substituted 6-phenylphenanthridines
MX2010003155A (es) 2007-10-04 2010-04-01 Hoffmann La Roche Derivados de ciclopropil aril amida y uso de los mismos.
WO2013096744A1 (en) 2011-12-21 2013-06-27 Novira Therapeutics, Inc. Hepatitis b antiviral agents
EA038942B1 (ru) 2012-08-28 2021-11-12 Янссен Сайенсиз Айрлэнд Юси Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
HUE034820T2 (en) 2013-02-28 2018-02-28 Janssen Sciences Ireland Uc Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
EA027068B1 (ru) 2013-04-03 2017-06-30 Янссен Сайенсиз Айрлэнд Юси Производные n-фенилкарбоксамида и их применение в качестве лекарственных препаратов для лечения гепатита b
EA035500B1 (ru) 2013-05-17 2020-06-25 Янссен Сайенсиз Айрлэнд Юси Производные сульфамоилтиофенамида и их применение в качестве медикаментов для лечения гепатита b
TWI651300B (zh) 2013-05-17 2019-02-21 健生科學愛爾蘭無限公司 胺磺醯基吡咯醯胺衍生物及其作為用於治療b型肝炎藥物的用途
DK3024819T3 (en) 2013-07-25 2018-06-06 Janssen Sciences Ireland Uc GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
KR102290189B1 (ko) 2013-10-23 2021-08-17 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 카르복스아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도
US9169212B2 (en) 2014-01-16 2015-10-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
US10392349B2 (en) 2014-01-16 2019-08-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
JP6553059B2 (ja) 2014-02-05 2019-07-31 ノヴィラ・セラピューティクス・インコーポレイテッド Hbv感染の治療のための併用療法
WO2015118057A1 (en) 2014-02-06 2015-08-13 Janssen Sciences Ireland Uc Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
EP3271019A1 (en) 2015-03-19 2018-01-24 Novira Therapeutics Inc. Azocane and azonane derivatives and methods of treating hepatitis b infections
US10875876B2 (en) 2015-07-02 2020-12-29 Janssen Sciences Ireland Uc Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
HK1259410A1 (zh) 2015-09-29 2019-11-29 诺维拉治疗公司 乙型肝炎抗病毒剂的晶体形式
SG10202011827YA (en) 2016-04-15 2021-01-28 Novira Therapeutics Inc Combinations and methods comprising a capsid assembly inhibitor
CA3090125A1 (en) 2018-03-14 2019-09-19 Janssen Sciences Ireland Unlimited Company Capsid assembly modulator dosing regimen
MX2021010145A (es) 2019-02-22 2021-09-14 Janssen Sciences Ireland Unlimited Co Derivados de amida utiles en el tratamiento de una infeccion por vhb o de enfermedades inducidas por vhb.
MA55879A (fr) 2019-05-06 2022-03-16 Janssen Sciences Ireland Unlimited Co Dérivés d'amide utiles dans le traitement d'une infection par le virus de l'hépatite b ou de maladies induites par le virus de l'hépatite b

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
UA48216C2 (uk) 1996-01-31 2002-08-15 Бік Гулден Ломберг Кеміше Фабрік Гмбх Фенантридини та лікарський засіб для лікування захворювань дихальних шляхів
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
WO1997035854A1 (de) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue in 6-position substituierte phenanthridine
EE03829B1 (et) * 1996-11-11 2002-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
JP2001514640A (ja) 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
CA2291153A1 (en) 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
DE69822162T2 (de) * 1997-07-25 2005-01-27 Altana Pharma Ag Neue tetrazolderivate
JP2001510827A (ja) * 1997-07-25 2001-08-07 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 置換6−フェニルフェナントリジン
ATE294793T1 (de) * 1999-01-15 2005-05-15 Altana Pharma Ag Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
WO2000042019A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-arylphenanthridines with pde-iv inhibiting activity
SI1147087T1 (en) * 1999-01-15 2005-10-31 Altana Pharma Ag Phenanthridine-n-oxides with pde-iv inhibiting activity

Similar Documents

Publication Publication Date Title
JP2002534508A5 (https=)
JP2003500442A5 (https=)
CA2494613A1 (en) Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
JP2006500370A5 (https=)
JP2005501120A5 (https=)
RU2009121775A (ru) Пиридильное неароматическое азот-содержащее гетероцикло-1-карбоксилатное производное
JP2008509187A5 (https=)
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
JP2005526144A5 (https=)
JP2002534506A5 (https=)
JP2003501474A5 (https=)
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
WO2005011656A3 (en) Pyridyl derivatives and their use as therapeutic agents
JP2006514626A5 (https=)
RU2007134380A (ru) Антибактериальные производные пиперидина
BR0210645A (pt) Composto derivado de tetraidroquinolina, composição farmacêutica, e, uso do composto.
DK1326613T3 (da) Anvendelse af substituerede imidazo[1,2-a] pyridin-, -pyrimidin- og -pyrazin-3-yl-amin-derivater til fremstilling af lægemidler til NOS-inhibering
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
JP2008534453A5 (https=)
CA2332087A1 (en) Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
JP2010536821A5 (https=)
JP2009541387A5 (https=)
JP2003502278A5 (https=)